Inventor · disambiguated record
Harold Meckler
Also filed as: MECKLER HAROLD
25 granted patents·8 pending applications·155 citations·filing 1989–2025
95Inventor score
Files withChemapotheca LLC8ALBANY MOLECULAR RES INC6CCT SCIENCES LLC4MECKLER HAROLD3PHARMAPOTHECA A INC3
Top patents by PatentIndex Score
33 records- 0194US9657041B2Chiral aryl or aryl-alkyl phosphoramidate dexamphetamine precursors having a regioisomeric purity >99%Chemapotheca LLC·Filed 2016·Granted May 23, 2017·9 cites·11 claims
- 0294US7674922B2Process for production of delta-9-tetrahydrocannabinolALBANY MOLECULAR RES INC·Filed 2006·Granted Mar 9, 2010·41 cites·77 claims
- 0393US10087202B2Chiral aziridine phosphoramidate compoundsChemapotheca LLC·Filed 2017·Granted Oct 2, 2018·6 cites·6 claims
- 0491US9278904B2Synthesis of chiral amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compoundsChemapotheca LLC·Filed 2014·Granted Mar 8, 2016·7 cites·20 claims
- 0590US11123310B2Amphetamine controlled release, prodrug, and abuse-deterrent dosage formsChemapotheca LLC·Filed 2017·Granted Sep 21, 2021·4 cites·43 claims
- 0689US12029718B2Process for production of essentially pure delta-9-tetrahydrocannabinolCCT SCIENCES LLC·Filed 2021·Granted Jul 9, 2024·1 cites·32 claims
- 0789US9321794B2Synthesis of racemic amphetamine derivatives by cuprate addition reaction with aziridine phosphoramidate compoundsChemapotheca LLC·Filed 2014·Granted Apr 26, 2016·7 cites·29 claims
- 0888US8106244B2Process for production of delta-9-tetrahydrocannabinolBURDICK DAVID C·Filed 2011·Granted Jan 31, 2012·10 cites·5 claims
- 0986US12458620B2Process for production of essentially pure Δ9-tetrahydrocannabinolCCT SCIENCES LLC·Filed 2024·Granted Nov 4, 2025·0 cites·32 claims
- 1085US6610866B2Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compoundsMAGAININ PHARMA·Filed 2001·Granted Aug 26, 2003·23 cites·22 claims
- 1176US7498345B2Process for production of piperidine derivativesALBANY MOLECULAR RES INC·Filed 2004·Granted Mar 3, 2009·6 cites·14 claims
- 1275US12006275B2Process for making levoamphetamineChemapotheca LLC·Filed 2020·Granted Jun 11, 2024·1 cites·20 claims
- 1368US7498443B2Process for production of carebastineALBANY MOLECULAR RES INC·Filed 2004·Granted Mar 3, 2009·3 cites·5 claims
- 1468US5096919APyrrolylphenyl-substituted hydroxamic acid derivativesCIBA GEIGY CORP·Filed 1989·Granted Mar 17, 1992·8 cites·22 claims
- 1566US11717498B2Methods of treatment using amphetamine controlled release, prodrug, and abuse deterrent dosage formsChemapotheca LLC·Filed 2020·Granted Aug 8, 2023·0 cites·32 claims
- 1665US2010069651A1Process for production of delta-9-tetrahydrocannabinolALBANY MOLECULAR RES INC·Filed 2009·Application pending·0 cites
- 1764US7863452B2Process for production of piperidine derivativesALBANY MOLECULAR RES INC·Filed 2009·Granted Jan 4, 2011·0 cites·7 claims
- 1864US7858798B2Process for production of carebastineALBANY MOLECULAR RES INC·Filed 2009·Granted Dec 28, 2010·0 cites·5 claims
- 1963US2024002358A1Optically clear, taste-masked, shelf-stable nano-emulsions containing cannabinoidsCCT SCIENCES LLC·Filed 2023·Application pending·0 cites
- 2063US2020352883A1Methods of treatment using amphetamine controlled release, prodrug, and abuse-deterrent dosage formsChemapotheca LLC·Filed 2020·Application pending·0 cites
- 2162US2025213502A1Amphetamine Controlled Release, Prodrug, and Abuse-deterrent Dosage FormsPHARMAPOTHECA A INC·Filed 2024·Application pending·0 cites
- 2259US12208068B2Amphetamine controlled release, prodrug, and abuse-deterrent dosage formsPHARMAPOTHECA A INC·Filed 2023·Granted Jan 28, 2025·0 cites·18 claims
- 2358US2025367161A1Process For Production Of Essentially Pure Delta-9-TetrahydrocannabinolCCT SCIENCES LLC·Filed 2025·Application pending·0 cites
- 2454US6262283B1Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compoundsMAGAININ PHARMA·Filed 1997·Granted Jul 17, 2001·11 cites·11 claims
- 2554US5712387AHigh yield stereospecific mannosylationTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Jan 27, 1998·8 cites·4 claims
- 2653US2025206698A1Process for Making Lisdexamfetamine DimesylatePHARMAPOTHECA A INC·Filed 2024·Application pending·0 cites
- 2752US8334266B2Process for and intermediates in the preparation of canfosfamide and its saltsBOULANGER WILLIAM A·Filed 2012·Granted Dec 18, 2012·0 cites·10 claims
- 2851US8067604B2Process for production of carebastineMECKLER HAROLD·Filed 2010·Granted Nov 29, 2011·0 cites·7 claims
- 2951US6359012B1Method for making 24(S)-hydroxyvitamin D2BONE CARE INT INC·Filed 1999·Granted Mar 19, 2002·10 cites·4 claims
- 3050US8198247B2Process for and intermediates in the preparation of canfosfamide and its saltsBOULANGER WILLIAM A·Filed 2004·Granted Jun 12, 2012·0 cites·2 claims
- 3150US8067605B2Process for production of piperidine derivativesMECKLER HAROLD·Filed 2010·Granted Nov 29, 2011·0 cites·7 claims
- 3242US2004116724A1Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compoundsFiled 2003·Application pending·0 cites
- 3334US2006047171A1Catalytic hydrogenation of nitriles to produce capsaicinoid derivatives and amine compounds, and methods for purifying and obtaining the polymorphs thereofMECKLER HAROLD·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Harold Meckler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →